Published in

Elsevier, The Lancet Respiratory Medicine, 6(9), p. 593-600, 2021

DOI: 10.1016/s2213-2600(20)30390-8

Links

Tools

Export citation

Search in Google Scholar

Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial

Journal article published in 2021 by Dean A. Fennell, Amy King, Seid Mohammed, Aarti Gaba, Margaret Hutka, Bruno Morgan, Adrian Nicholson, Cathy Richards, Peter Wells-Jordan, Gavin James Murphy, Anne Thomas, Dean Anthony Fennell, Alan George Dawson, Charlotte Poile, Molly Scotland and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO